Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units

Author:

Godet Marie12,Simar Joanna1,Closset Mélanie1,Hecq Jean-Daniel32,Braibant Maximilien3,Soumoy Laura3,Gillet Patricia3,Jamart Jacques42,Bihin Benoît42,Galanti Laurence12

Affiliation:

1. Medical Laboratory , CHU UCL Namur , Yvoir , Belgium

2. Drug Stability Research Group , CHU UCL Namur , Yvoir , Belgium

3. Department of Pharmacy , CHU UCL Namur , Yvoir , Belgium

4. Scientific Support Unit , CHU UCL Namur , Yvoir , Belgium

Abstract

Abstract Background Vancomycin is increasingly administrated by continuous infusion. But the treatment of patient in intensive care need restricted volume to prevent fluid overload. The aim of the study was to evaluate the physical and chemical stability of solutions of a high concentration of vancomycin hydrochloride in 5 % glucose or 0.9 % NaCl. Methods Eight syringes of 50 mL, containing 41.66 mg/mL of vancomycin hydrochloride four syringes in 5 % glucose and four in 0.9 % NaCl were prepared and stored at ambient temperature during 48 h. Immediately after preparation and during 48 h, vancomycin hydrochloride concentrations were measured by a high-performance liquid chromatography (HPLC). Spectrophotometric absorbance at different wavelengths, pH measurement and microscopic observations were also performed. Results All solutions were physico-chemically stable during the whole period storage at ambient temperature: no color change, turbidity, precipitation or opacity, no significant pH variations or optic densities were observed in the solutions. Any crystals were seen by microscopic analysis. Solutions are considered chemically stable as the lower limit of the 95 % unilateral confidence interval on the mean remained above 90 % of the initial concentration for at least 48 h. Conclusions Solutions of vancomycin hydrochloride 41.66 mg/mL in syringe of 5 % glucose or 0.9 % NaCl are physically and chemically stable for at least 48 h when stored in syringes at ambient temperature.

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Reference33 articles.

1. Sweetman SC, editor. Martindale: the complete drug reference. 36th ed. London, UK: Pharmaceutical Press, 2009.

2. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990;34:1227–31.

3. Nachega J, Van Bambeke F, Vandercam B, Tulkens P. Usages cliniques actuels et raisonnables des glycopeptides. Louvain Med 1997;116:162–74.

4. Ampe E, Delaere B, Hecq JD, Tulkens P, Glupczynski Y. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects. Int J Antimicrob Agents 2013;41:439–46.

5. Koundalijan J. Setting up a CIVAS. In: Needle R, Sizer T., et al., editors. The CIVAS handbook, 1st ed. London: Pharmaceutical Press, 1998:1–5.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3